Rheumatoid Arthritis-associated Interstitial Lung Disease Definition

NCT06184893 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2023-12-28

No results posted yet for this study

Summary

This is a prospective multicenter study in southern Belgium to determine the prevalence and incidence of interstitial lung disease in patients with rheumatoid arthritis (RA).

Conditions

  • Rheumatoid Arthritis-Associated Interstitial Lung Disease

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-20
Primary Completion
2025-10-31
Completion
2025-10-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06184893 on ClinicalTrials.gov